Creo Medical Group Stock Total Debt
| CREO Stock | 16.63 0.50 3.10% |
Creo Medical Group fundamentals help investors to digest information that contributes to Creo Medical's financial success or failures. It also enables traders to predict the movement of Creo Stock. The fundamental analysis module provides a way to measure Creo Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Creo Medical stock.
Creo | Total Debt |
Creo Medical Group Company Total Debt Analysis
Creo Medical's Total Debt refers to the amount of long term interest-bearing liabilities that a company carries on its balance sheet. That may include bonds sold to the public, notes written to banks or capital leases. Typically, debt can help a company magnify its earnings, but the burden of interest and principal payments will eventually prevent the firm from borrow excessively.
Current Creo Medical Total Debt | 8.3 M |
Most of Creo Medical's fundamental indicators, such as Total Debt, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Creo Medical Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In most industries, total debt may also include the current portion of long-term debt. Since debt terms vary widely from one company to another, simply comparing outstanding debt obligations between different companies may not be adequate. It is usually meant to compare total debt amounts between companies that operate within the same sector.
| Competition |
Creo Net Debt
Net Debt |
|
Based on the latest financial disclosure, Creo Medical Group has a Total Debt of 8.3 M. This is much higher than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The total debt for all United Kingdom stocks is notably lower than that of the firm.
Creo Total Debt Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Creo Medical's direct or indirect competition against its Total Debt to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Creo Medical could also be used in its relative valuation, which is a method of valuing Creo Medical by comparing valuation metrics of similar companies.Creo Medical is currently under evaluation in total debt category among its peers.
Creo Fundamentals
| Return On Equity | -0.38 | ||||
| Return On Asset | -0.2 | ||||
| Profit Margin | (0.74) % | ||||
| Operating Margin | (0.89) % | ||||
| Current Valuation | 72.92 M | ||||
| Shares Outstanding | 412.15 M | ||||
| Shares Owned By Insiders | 20.44 % | ||||
| Shares Owned By Institutions | 48.82 % | ||||
| Price To Book | 1.45 X | ||||
| Price To Sales | 2.26 X | ||||
| Revenue | 30.8 M | ||||
| Gross Profit | 11.59 M | ||||
| EBITDA | (20.7 M) | ||||
| Net Income | (21.7 M) | ||||
| Total Debt | 8.3 M | ||||
| Book Value Per Share | 0.13 X | ||||
| Cash Flow From Operations | (21.6 M) | ||||
| Earnings Per Share | (0.06) X | ||||
| Target Price | 57.5 | ||||
| Number Of Employees | 278 | ||||
| Beta | 0.85 | ||||
| Market Capitalization | 68.52 M | ||||
| Total Asset | 76.6 M | ||||
| Retained Earnings | (130.8 M) | ||||
| Working Capital | 28 M | ||||
| Net Asset | 76.6 M |
About Creo Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Creo Medical Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Creo Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Creo Medical Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Creo Stock Analysis
When running Creo Medical's price analysis, check to measure Creo Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Creo Medical is operating at the current time. Most of Creo Medical's value examination focuses on studying past and present price action to predict the probability of Creo Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Creo Medical's price. Additionally, you may evaluate how the addition of Creo Medical to your portfolios can decrease your overall portfolio volatility.